Drug Trial Radar · NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
751
Planned (sponsor's estimate)
Start
Jan 22, 2026
Primary completion
Aug 13, 2029
Study completion Mar 20, 2034
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Teva Branded Pharmaceutical Products R&D LLC
- First posted
- Sep 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-Up visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in the Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visits will be up to 43: - 21 visits in the Pivotal Maintenance Sub-Study - 22 visits in the OLE Sub-Study
Conditions
- Crohn's Disease
Interventions
DuvakitugDrug
Pharmaceutical form:Injection solution-Route of administration:SC injection
PlaceboDrug
Pharmaceutical form:Injection solution-Route of administration:SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary endpoints US/FDA: Pivotal Maintenance Sub-Study Cohort 1 Proportion of participants achieving clinical remission (CDAI) at Week 40Time frame: Week 40
- Proportion of participants achieving Endoscopic Response (SES-CD) at Week 40Time frame: Week 40
- Co-primary endpoints EU/EMA: Pivotal Maintenance Sub-Study Cohort 1 Proportion of participants achieving clinical remission per PRO-2 at Week 40Time frame: Week 40
Locations
109 sites in 27 countries. Site status is shown where the registry gives one.
Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039
Colorado Springs, Colorado · Recruiting
Clinical Research of Osceola-Site Number: 8400013
Kissimmee, Florida · Recruiting
Columbus Clinical Services LLc-Site Number: 8400038
Miami, Florida · Recruiting
Bioresearch Partner-Kendale Lakes-Site Number: 8400053
Miami, Florida · Recruiting
Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084
Orlando, Florida · Recruiting
NMC Research LLC-Site Number: 8400033
Tampa, Florida · Recruiting
Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049
Gurnee, Illinois · Recruiting
Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100
New Albany, Indiana · Recruiting
GI Alliance - Baton Rouge-Site Number: 8400129
Baton Rouge, Louisiana · Recruiting
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville-Site Number: 8400128
Mandeville, Louisiana · Recruiting
GI Alliance - Metairie-Site Number: 8400124
Metairie, Louisiana · Recruiting
Delta Research Partners-Site Number: 8400087
Monroe, Louisiana · Recruiting
BVL Clinical Research-Site Number: 8400005
Liberty, Missouri · Recruiting
Gateway Gastroenterology-Site Number: 8400097
St Louis, Missouri · Recruiting
MedTraits NY-Site Number: 8400045
Maspeth, New York · Recruiting
NYU Langone Health-Site Number: 8400091
New York, New York · Recruiting
Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040
New York, New York · Recruiting
New York Gastroenterology Associates-Site Number: 8400009
New York, New York · Recruiting
UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074
Chapel Hill, North Carolina · Recruiting
Cross Creek Medical Clinic-Site Number: 8400057
Fayetteville, North Carolina · Recruiting
Ohio Gastroenterology Group Inc.-Site Number: 8400006
Columbus, Ohio · Recruiting
Medical Associates Research Group-Site Number: 8400063
Columbus, Ohio · Recruiting
OSU Wexner Medical Center-Site Number: 8400077
Columbus, Ohio · Recruiting
North Shore Gastroenterology Research-Site Number: 8400130
Westlake, Ohio · Recruiting
University of Pennsylvania School of Medicine-Site Number: 8400072
Philadelphia, Pennsylvania · Recruiting
The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107
Pittsburgh, Pennsylvania · Recruiting
University Gastroenterology - GI Alliance-Site Number: 8400103
Providence, Rhode Island · Recruiting
GI Alliance - Lubbock-Site Number: 8400092
Lubbock, Texas · Recruiting
SMS Clinical Research-Site Number: 8400035
Mesquite, Texas · Recruiting
Gastroenterology Research of San Antonio LLC-Site Number: 8400054
San Antonio, Texas · Recruiting
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake-Site Number: 8400101
Southlake, Texas · Recruiting
Tyler Research Institute LLC-Site Number: 8400095
Tyler, Texas · Recruiting
The Vancouver Clinic Inc. P.S.-Site Number: 8400090
Vancouver, Washington · Recruiting
Gastroenterology Associates of Western Michigan-Site Number: 8400060
Wyoming, Wyoming · Recruiting
Investigational Site Number : 0400002
Salzburg, Australia · Recruiting
Investigational Site Number : 0400007
Vienna, Australia · Recruiting
Investigational Site Number : 0360001
South Brisbane, Queensland, Australia · Recruiting
Investigational Site Number : 0400001
Vienna, Austria · Recruiting
Investigational Site Number : 0560003
Yvoir, Belgium · Recruiting
Sao Jose do Rio Preto Regional Faculty of Medicine Foundation-Site Number: 0760006
São José do Rio Preto, Brazil · Recruiting
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.